Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model
- DOI
- 10.1158/0008-5472.can-08-1723
- Published
- 2008-10-30
- Container
- Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-08-1723,
title = {Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model},
author = {Boris Gorelik and Irit Ziv and Revital Shohat and Michael Wick and W. David Hankins and David Sidransky and Zvia Agur},
year = {2008},
journal = {Cancer Research},
doi = {10.1158/0008-5472.can-08-1723},
url = {https://doi.org/10.1158/0008-5472.can-08-1723}
}RIS
TY - JOUR TI - Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model AU - Boris Gorelik AU - Irit Ziv AU - Revital Shohat AU - Michael Wick AU - W. David Hankins AU - David Sidransky AU - Zvia Agur PY - 2008 JO - Cancer Research DO - 10.1158/0008-5472.can-08-1723 UR - https://doi.org/10.1158/0008-5472.can-08-1723 ER -
APA
Gorelik, B., Ziv, I., Shohat, R., Wick, M., Hankins, W. D., Sidransky, D., & Agur, Z. (2008). Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-1723
Source records
- crossref · retrieved 2026-09-26T11:26:09.452Z